• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 感染后亚急性甲状腺炎的成功治疗。

Successful Management of Subacute Thyroiditis Following SARS-CoV-2 Infection.

机构信息

Department of Internal Medicine, Hayama Heart Center, Japan.

Department of General Internal Medicine, Shonan Kamakura General Hospital, Japan.

出版信息

Intern Med. 2021 Nov 15;60(22):3573-3576. doi: 10.2169/internalmedicine.7913-21. Epub 2021 Sep 11.

DOI:10.2169/internalmedicine.7913-21
PMID:34511569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8666218/
Abstract

Subacute thyroiditis (SAT) is a disorder of the thyroid gland and difficult to diagnose. It is probably triggered by a viral infection. Recently, several articles have reported SAT after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, reports describing SAT after SARS-CoV-2 in Japan are lacking. We herein report the first case of SAT after SARS-CoV-2 infection in Japan. After SARS-CoV-2 infection, some patients can develop not only pneumonia but also SAT. Thus, a careful follow-up is recommended for patients after SARS-CoV-2 infection. Furthermore, the effect of SARS-CoV-2 infection on thyroid dysfunction should not be ignored.

摘要

亚急性甲状腺炎(SAT)是一种甲状腺疾病,难以诊断。它可能由病毒感染引发。最近,有几篇文章报道了严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染后的 SAT。然而,目前尚无关于日本 SARS-CoV-2 感染后 SAT 的报道。我们在此报告首例日本 SARS-CoV-2 感染后的 SAT 病例。SARS-CoV-2 感染后,部分患者不仅可发生肺炎,还可发生 SAT。因此,建议对 SARS-CoV-2 感染患者进行密切随访。此外,不应忽视 SARS-CoV-2 感染对甲状腺功能障碍的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa45/8666218/d0d76176edfb/1349-7235-60-3573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa45/8666218/791890ce4c2a/1349-7235-60-3573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa45/8666218/35facb5ecc19/1349-7235-60-3573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa45/8666218/d0d76176edfb/1349-7235-60-3573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa45/8666218/791890ce4c2a/1349-7235-60-3573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa45/8666218/35facb5ecc19/1349-7235-60-3573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa45/8666218/d0d76176edfb/1349-7235-60-3573-g003.jpg

相似文献

1
Successful Management of Subacute Thyroiditis Following SARS-CoV-2 Infection.SARS-CoV-2 感染后亚急性甲状腺炎的成功治疗。
Intern Med. 2021 Nov 15;60(22):3573-3576. doi: 10.2169/internalmedicine.7913-21. Epub 2021 Sep 11.
2
Subacute Thyroiditis After Sars-COV-2 Infection.感染 SARS-CoV-2 后发生亚急性甲状腺炎。
J Clin Endocrinol Metab. 2020 Jul 1;105(7). doi: 10.1210/clinem/dgaa276.
3
Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series.亚急性甲状腺炎是 SARS-CoV-2 感染的被低估表现吗?一项病例系列研究的启示。
J Clin Endocrinol Metab. 2020 Oct 1;105(10). doi: 10.1210/clinem/dgaa537.
4
HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.接种 SARS-CoV-2 疫苗后发生亚急性甲状腺炎和格雷夫斯病的患者的 HLA 分型:病例报告。
BMC Endocr Disord. 2023 Mar 7;23(1):54. doi: 10.1186/s12902-023-01287-5.
5
Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome.三例接种 SARS-CoV-2 疫苗后亚急性甲状腺炎:疫苗接种后 ASIA 综合征。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):2600-2605. doi: 10.1210/clinem/dgab373.
6
New aspects in the pathogenesis and management of subacute thyroiditis.亚急性甲状腺炎发病机制和治疗的新方面。
Rev Endocr Metab Disord. 2021 Dec;22(4):1027-1039. doi: 10.1007/s11154-021-09648-y. Epub 2021 May 5.
7
SARS-CoV-2 Vaccine-induced Thyroiditis: Safety of Revaccinations and Clinical Follow-up.SARS-CoV-2 疫苗诱导的甲状腺炎:再接种的安全性和临床随访。
J Clin Endocrinol Metab. 2022 Apr 19;107(5):e1823-e1834. doi: 10.1210/clinem/dgac049.
8
Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review.COVID-19 继发亚急性甲状腺炎的危险因素、治疗方法和结局:系统评价。
Intern Med J. 2022 Apr;52(4):522-529. doi: 10.1111/imj.15432.
9
Subacute thyroiditis following COVID-19 vaccination: Case presentation.接种 COVID-19 疫苗后的亚急性甲状腺炎:病例报告。
Antivir Ther. 2023 Oct;28(5):13596535231208831. doi: 10.1177/13596535231208831.
10
Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review.SARS-CoV-2 相关亚急性甲状腺炎患者的临床、生化特征和功能结局:综述。
Endocrine. 2023 Mar;79(3):448-454. doi: 10.1007/s12020-022-03247-w. Epub 2022 Nov 17.

引用本文的文献

1
Case Report: SARS-CoV-2-associated immune dysfunction manifesting as concurrent fulminant type 1 diabetes mellitus and subacute thyroiditis.病例报告:SARS-CoV-2相关免疫功能障碍表现为暴发性1型糖尿病和亚急性甲状腺炎并发。
Front Med (Lausanne). 2025 Aug 18;12:1644656. doi: 10.3389/fmed.2025.1644656. eCollection 2025.
2
Subacute thyroiditis as a post-COVID-19 complication: a systematic review.新冠后亚急性甲状腺炎并发症:一项系统综述
BMC Infect Dis. 2025 Jul 1;25(1):862. doi: 10.1186/s12879-025-10518-0.
3
Thyroid function during COVID-19 and post-COVID complications in adults: a systematic review.

本文引用的文献

1
Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review.COVID-19 继发亚急性甲状腺炎的危险因素、治疗方法和结局:系统评价。
Intern Med J. 2022 Apr;52(4):522-529. doi: 10.1111/imj.15432.
2
Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications.新型冠状病毒肺炎相关低钙血症:患病率、临床意义及治疗影响。
Rev Endocr Metab Disord. 2022 Apr;23(2):299-308. doi: 10.1007/s11154-021-09655-z. Epub 2021 Apr 13.
3
A 33-year-old man with COVID-19 presented with subacute thyroiditis: A rare case report and literature review.
成人新冠病毒感染期间的甲状腺功能及新冠后并发症:一项系统综述
Front Endocrinol (Lausanne). 2025 Feb 4;15:1477389. doi: 10.3389/fendo.2024.1477389. eCollection 2024.
4
Long-Term Impacts of COVID-19 on Thyroid Health: Insights From Clinical Studies.新冠病毒病对甲状腺健康的长期影响:来自临床研究的见解
Cureus. 2024 Oct 14;16(10):e71469. doi: 10.7759/cureus.71469. eCollection 2024 Oct.
5
Subacute Thyroiditis in Active COVID-19 Infection: A Report of Two Cases With a Systematic Review of the Literature.新型冠状病毒肺炎(COVID-19)感染活动期的亚急性甲状腺炎:两例报告及文献系统综述
Cureus. 2024 Jan 20;16(1):e52611. doi: 10.7759/cureus.52611. eCollection 2024 Jan.
6
Clinical Aspects in Subacute Thyroiditis: A Real-Life Study on 226 Cases in Greece Amid the COVID-19 Pandemic.亚急性甲状腺炎的临床情况:希腊在新冠疫情期间对226例病例的实际研究
J Clin Med. 2023 Nov 18;12(22):7171. doi: 10.3390/jcm12227171.
7
Concurrent Subacute Thyroiditis and Graves' Disease After COVID-19: A Case Report.新冠病毒感染后同时发生亚急性甲状腺炎和 Graves 病:病例报告。
J Korean Med Sci. 2023 May 8;38(18):e134. doi: 10.3346/jkms.2023.38.e134.
8
Subacute thyroiditis following COVID-19: A systematic review.COVID-19 后亚急性甲状腺炎:系统评价。
Front Endocrinol (Lausanne). 2023 Apr 5;14:1126637. doi: 10.3389/fendo.2023.1126637. eCollection 2023.
9
Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review.SARS-CoV-2 相关亚急性甲状腺炎患者的临床、生化特征和功能结局:综述。
Endocrine. 2023 Mar;79(3):448-454. doi: 10.1007/s12020-022-03247-w. Epub 2022 Nov 17.
10
Subacute Thyroiditis after COVID-19: A Literature Review.新冠病毒感染后亚急性甲状腺炎:文献综述
Am J Trop Med Hyg. 2022 Sep 6;107(5):1074-1082. doi: 10.4269/ajtmh.21-1223. Print 2022 Nov 14.
一名患有新型冠状病毒肺炎的33岁男性出现亚急性甲状腺炎:一例罕见病例报告及文献综述。
New Microbes New Infect. 2021 May;41:100871. doi: 10.1016/j.nmni.2021.100871. Epub 2021 Mar 22.
4
Subacute Thyroiditis from COVID-19 Infection: A Case Report and Review of Literature.新冠病毒感染所致亚急性甲状腺炎:一例报告及文献综述
Eur Thyroid J. 2021 Feb;9(6):324-328. doi: 10.1159/000511872. Epub 2020 Nov 5.
5
Subacute Thyroiditis in COVID-19 Patients.新冠病毒感染患者中的亚急性甲状腺炎
Eur Thyroid J. 2021 Feb;9(6):321-323. doi: 10.1159/000511707. Epub 2020 Oct 30.
6
Potential Interaction Between SARS-CoV-2 and Thyroid: A Review.新型冠状病毒与甲状腺之间潜在的相互作用:综述。
Endocrinology. 2021 Mar 1;162(3). doi: 10.1210/endocr/bqab004.
7
A Case of Post-COVID-19 Subacute Thyroiditis.1例新型冠状病毒肺炎后亚急性甲状腺炎病例
Cureus. 2020 Dec 26;12(12):e12301. doi: 10.7759/cureus.12301.
8
Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity.亚急性甲状腺炎作为 COVID-19 的表现之一:一个极其罕见的临床实体的报告。
BMJ Case Rep. 2020 Dec 18;13(12):e239953. doi: 10.1136/bcr-2020-239953.
9
SUBACUTE THYROIDITIS IN A PATIENT WITH CORONAVIRUS DISEASE 2019.一名2019冠状病毒病患者的亚急性甲状腺炎
AACE Clin Case Rep. 2020 Nov 23;6(6):e361-e364. doi: 10.4158/ACCR-2020-0524. eCollection 2020 Nov-Dec.
10
Subacute thyroiditis might be a complication triggered by SARS-CoV-2.亚急性甲状腺炎可能是由新型冠状病毒引发的一种并发症。
Endocrinol Diabetes Nutr (Engl Ed). 2020 Oct 13;68(10):755-6. doi: 10.1016/j.endinu.2020.09.002.